Investor insights
Sectors invested in
Biotechnology2
Pharmaceutical2
RNAscope1
safety toxicology1
Biometrics1
ISH1
Quantitative Molecular Detection1
companion diagnostics1
CDx1
Morphological Context1
RNA-Seq1
target validation1
Fluorescent in situ hybridization (FISH)1
antibody validation1
splice variants1
Chromogenic in situ hybridization (CISH)1
RNA biomarkers1
gene therapy1
RNA in situ hybridization1
BaseScope1
Funding rounds participated in
$51M sweet spot round size
Most of their 2 investments are in rounds between $22M and $80M
Investor type
Venture Capital
Basic info
Industry
biotechnology research
Sectors
Date founded
1999
Investments made
T
Turning Point Therapeutics raised $80M on October 19, 2018
Investors: Lilly Asia Ventures, Nextech Invest, Foresite Capital, venBio Partners, S.R. One Ltd, OrbiMed Advisors and Kenson Ventures
A
Advanced Cell Diagnostics raised $22M on June 18, 2015
Investors: Summit Partners, New Leaf Venture Partners and Kenson Ventures